About the work
Despite a strong correlation to outcome, the measurement of gray matter (GM) atrophy is not being used in daily clinical practice as a prognostic factor and monitor the effect of treatments in Multiple Sclerosis (MS). This is mainly because the volumetric methods available to date are sophisticated and difficult to implement for routine use in most hospitals. In addition, the meaning of raw results from volumetric studies on regions of interest are not always easy to understand. Thus, there is a
Print work information
Work information
Title The yearly rate of Relative Thalamic Atrophy (yrRTA): a simple 2D/3D method for estimating deep gray matter atrophy in Multiple Sclerosis
Despite a strong correlation to outcome, the measurement of gray matter (GM) atrophy is not being used in daily clinical practice as a prognostic factor and monitor the effect of treatments in Multiple Sclerosis (MS). This is mainly because the volumetric methods available to date are sophisticated and difficult to implement for routine use in most hospitals. In addition, the meaning of raw results from volumetric studies on regions of interest are not always easy to understand. Thus, there is a
Work type Article
Tags biomarker, brain atrophy, multiple sclerosis, neurodegenerative disease, parkinson, neurodegenerative disease, brain atrophy, alzheimer, parkinson, neuroimaging, multiple sclerosis, neuroimaging, yrrta, alzheimer, biomarker
-------------------------
Registry info in Safe Creative
Identifier 1411222576348
Entry date Nov 22, 2014, 6:05 PM UTC
License All rights reserved
-------------------------
Copyright registered declarations
Author. Holder Manuel Menendez Gonzalez. Date Nov 22, 2014.
Information available at https://www.safecreative.org/work/1411222576348-the-yearly-rate-of-relative-thalamic-atrophy-yrrta-a-simple-2d-3d-method-for-estimating-deep-gray-matter-atrophy-in-multiple-sclerosis
/
Registration: 1411222576348
